A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

Trial Profile

A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 20 May 2016

At a glance

  • Drugs MEDI 0457 (Primary) ; Cisplatin
  • Indications Cervical cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 May 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 14 Jan 2016 Planned End Date changed from 1 Dec 2020 to 1 May 2021 as per ClinicalTrials.gov record.
    • 14 Jan 2016 Planned primary completion date changed from 1 Dec 2018 to 1 May 2019 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top